Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a content management/versioning update rather than changes to the clinical study details.
    Difference
    0.1%
    Check dated 2026-04-24T22:20:45.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2. No visible content changes are indicated.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:54.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The Locations section was updated with new entries for Paris and Villejuif in Val-de-Marne, and some existing address lines were removed or reformatted.
    Difference
    0.9%
    Check dated 2026-04-03T05:31:33.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Only minor layout and wording tweaks observed; core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-03-27T01:41:14.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    Page revision updated: v3.4.3 replaced with v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T22:17:09.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added and v3.4.1 removed, a minor UI/version update that does not affect study details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:18:53.000Z thumbnail image

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.